[HTML][HTML] Applications of proteomics in ovarian cancer: dawn of a new era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - mdpi.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - …, 2022 - pubmed.ncbi.nlm.nih.gov
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era.
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - europepmc.org
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
[PDF][PDF] Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. Proteomes 2022, 10, 16
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - 2022 - researchgate.net
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - 2022 - agris.fao.org
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - …, 2022 - search.proquest.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
[HTML][HTML] Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - ncbi.nlm.nih.gov
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era.
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - …, 2022 - search.ebscohost.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …